Clinical Trial Update: An Epidemiological Study of Acute Coronary Syndromes in The Greek Population. The TARGET Study

View source ↗

Summary

This document reports the completion of the TARGET Study, an epidemiological study of acute coronary syndromes in the Greek population sponsored by AstraZeneca.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndromes

Snippet

Sponsor: AstraZeneca | Conditions: Acute Coronary Syndromes | Status: COMPLETED